MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the opening of the Henry Schein Cares Foundation 2025 Relief Fund to support the Los Angeles area fires. Contribution...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers throughout California that the Henry Schein Customer Emergency Support Hotline is open for dental and medical p...

Henry Schein has strategically set up distribution centers worldwide to better serve customers and increase its operating efficiency.

Investors are optimistic about HSIC owing to the performance of its dental business.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to participate at J.P. Morgan's Healthcare Investor Conference.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Ananym Capital is calling for changes at Henry Schein, which may help the company improve its profitability.

Henry Schein inked a new agreement to acquire Acentus to enhance its ability to deliver CGM products directly to patients' homes.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to participate in investor conferences in December.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to acquire Acentus, a leading supplier of homecare medical products.

Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribu...

Henry Schein shares climbed more than 4% in Monday trading, on track to notch their best day since July. Financial firm Gordon Haskett said Robert F.

Henry Schein, Inc. (NASDAQ:HSIC ) Q3 2024 Earnings Conference Call November 5, 2024 10:00 AM ET Company Participants Graham Stanley - VP, IR & Strategic Financial Project Officer Stanley Bergman - Cha...

The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street...

Henry Schein's third-quarter results reflect an improvement in sales trends in Technology and Value-Added Services business.

Henry Schein (HSIC) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.32 per share a year ago.

Dental products distributor Henry Schein beat third-quarter profit estimates on Tuesday, as a series of cost-saving measures helped counter tepid demand and slow recovery from a cyberattack it disclos...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein reports third quarter 2024 financial results and increases 2024 financial guidance.